Get started
DENALI THERAP.INC. DL-,01DENALI THERAP.INC. DL-,01DENALI THERAP.INC. DL-,01

DENALI THERAP.INC. DL-,01

No trades
See on Supercharts
Overview
Financials News Ideas Minds Forecast

4DN chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪2.87 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.860EUR
Net income (FY)
‪−131.57 M‬EUR
Revenue (FY)
‪299.46 M‬EUR
Shares float
‪117.17 M‬
Beta (1Y)
2.56

About Denali Therapeutics Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Ryan J. Watts
Website
denalitherapeutics.com
Headquarters
San Francisco
Employees (FY)
445
Founded
2013
FIGI
BBG00JH1NN65
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DENALI THERAP.INC. DL-,01 stocks are traded under the ticker 4DN.
We've gathered analysts' opinions on DENALI THERAP.INC. DL-,01 future price: according to them, 4DN price has a max estimate of 87.60 EUR and a min estimate of 20.29 EUR. Watch 4DN chart and read a more detailed DENALI THERAP.INC. DL-,01 stock forecast: see what analysts think of DENALI THERAP.INC. DL-,01 and suggest that you do with its stocks.
4DN reached its all-time high on Dec 23, 2020 with the price of 75.900 EUR, and its all-time low was 10.440 EUR and was reached on Jul 31, 2018. View more price dynamics on 4DN chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track DENALI THERAP.INC. DL-,01 financials in yearly and quarterly reports right on TradingView.
DENALI THERAP.INC. DL-,01 is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
4DN earnings for the last quarter are −0.63 EUR per share, whereas the estimation was −0.64 EUR resulting in a 2.15% surprise. The estimated earnings for the next quarter are −0.62 EUR per share. See more details about DENALI THERAP.INC. DL-,01 earnings.
DENALI THERAP.INC. DL-,01 revenue for the last quarter amounts to 0 EUR, despite the estimated figure of ‪13.00 M‬ EUR. In the next quarter revenue is expected to reach ‪9.20 M‬ EUR.
4DN net income for the last quarter is ‪−94.35 M‬ EUR, while the quarter before that showed ‪−108.24 M‬ EUR of net income which accounts for 12.84% change. Track more DENALI THERAP.INC. DL-,01 financial stats to get the full picture.
No, 4DN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 6, 2024, the company has 445.00 employees. See our rating of the largest employees — is DENALI THERAP.INC. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DENALI THERAP.INC. DL-,01 EBITDA is ‪−185.56 M‬ EUR, and current EBITDA margin is −54.45%. See more stats in DENALI THERAP.INC. DL-,01 financial statements.
Like other stocks, 4DN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DENALI THERAP.INC. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.